US Patent 8445527 Organic compounds and their uses
Patent 8445527 was granted and assigned to Novartis on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+153 characters)
Article
Patent abstract
The present invention provides a method of treating a HCV infection in a subject in need thereof by administering a compound of Formula I:
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Aregahegn Yifru0
Branko Radetich0
David Thomas Parker0
Francois Lenoir0
Jiping Fu0
Michael Patane0
Mohindra Seepersaud0
Oliver Simic0
Pascal Rigollier0
Prakash Raman0
Rui Zheng0
Trixi Brandl0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08445527 Organic compounds and their uses US Patent 8445527 Organic compounds and their uses
Infobox
Patent Number
084455270
Patent Number
84455270
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084455270
Date of Patent
May 21, 2013
0Patent Application Number
134778660
Date Filed
May 22, 2012
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08445527 Organic compounds and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08445527
Date of patent
May 21, 2013
Patent application number
13477866
Date Filed
May 22, 2012
Patent primary examiner
Find more entities like US Patent 8445527 Organic compounds and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
